Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by balainon Sep 10, 2017 7:51pm
237 Views
Post# 26677782

RE:RE:Small Cap Index

RE:RE:Small Cap IndexYes Stag, you are correct, we were on it. Then the misleading report from Black Mamba came out on PLI last November, the price swings became out of control, way too volatile for the index I suppose, and they decided to remove us. No other reasons were given other than inclusion and deletion from the index.

Now that the share price is this low, and that things are looking rosy again, they decided to reinstate us. I suppose that it looks good for the index if they have a rocketing stock that is part of it ;)

I can say that things are definitely looking up again. Just need the approval of Plasminogen from the FDA and it may change the perception that the markets have towards the company. It sure can't come fast enough.

Hopefully the full turnaround starts tomorrow with the Morgan Stanley Global Healthcare conference. We will soon find out if PLI's pitch is making waves with deep pocketed investors this time around, or if we go through another nightmarish phase awaiting the next financing...I doubt we see the latter :)

GLTA

balain
Bullboard Posts